(Q43430455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Quantitative motor assessment in myotonic dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J Mathieu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Boivin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C L Richards

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

129-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100053397

1 reference

7 January 2021

Issues in clinical trial design I: Use of natural history controls. A protagonist view

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Manual muscle testing

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

A rating scale for amyotrophic lateral sclerosis: description and preliminary experience

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Randomized controlled trial of testosterone in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada)

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

The natural history of motoneuron loss in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Quantitative motor assessment in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100053397

7 January 2021

10.1017/S0317167100053397

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12774952%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference